https://www.selleckchem.com/products/ho-3867.html Mobile health (mHealth) apps have played an important role in mitigating the coronavirus disease (COVID-19) response. However, there is no resource that provides a holistic picture of the available mHealth apps that have been developed to combat this pandemic. Our aim is to scope the evidence base on apps that were developed in response to COVID-19. Following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines for scoping reviews, literature searches were conducted on Google Search, Google Scholar, and PubMed using the country's name as keywords and "coronavirus," "COVID-19," "nCOV19," "contact tracing," "information providing apps," "symptom tracking," "mobile apps," "mobile applications," "smartphone," "mobile phone," and "mHealth." Countries most affected by COVID-19 and those that first rolled out COVID-19-related apps were included. A total of 46 articles were reviewed from 19 countries, resulting in a total of 29 apps. Among them, 15 (52%) apps were on contf good practices across different countries can enable governments to learn from each other and develop effective strategies to combat and manage this pandemic.Relapsing polychondritis (RP) is an inflammatory disease that involves cartilaginous structures predominantly in the nose, ears, and respiratory tract. Cardiovascular involvement is not common. Despite this, they are the second cause of death in patients with RP. The structures usually affected by this disease are the heart valves, with regurgitation being the most common valvulopathy. We present the case of a patient without the previous diagnosis of RP who was referred to our institute with heart failure secondary to aortic regurgitation, initially attributed to endocarditis.Science and technology are modifying medicine at a dizzying pace. Although access in our country to the benefits of innovations in the area of devices, data storage and artificial intelligen